Robert Mader

11PUBLICATIONS
24CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Polymerisation mechanismsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 25, 2025
Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages.

Karin Kosulin, Trevor L Brasel, Jeanon Smith

|Aug 25, 2023
Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.

Thomas Bartl, Christoph Grimm, Robert M Mader

|Feb 27, 2023
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo.

Paul Strasser, Bianca Montsch, Silvia Weiss

|Apr 23, 2022
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.

Hossein Taghizadeh, Agnieszka Maj-Hes, Gerald W Prager

|Apr 28, 2021
Tissue distribution of epirubicin after severe extravasation in humans.

Jakob Nedomansky, Werner Haslik, Ursula Pluschnig

Pageof 2